Gary Glick (Scorpion Therapeutics)
Serial entrepreneur Gary Glick sells another one of his startups for $229M — this time to an unlikely buyer
Gary Glick has proven himself, time and again, a nifty startup artist. After selling Lycera to Celgene, he held a streak for IFM Therapeutics …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
